Kissei Pharmaceutical : Announces New President and COO
April 23, 2018 at 02:13 am EDT
Share
Kissei Pharmaceutical Co., Ltd.
At the meeting of our Company's Board of Directors on April 23, 2018, a decision was made to change the President as follows.
This change will be authorized at the regular shareholders' meeting and at the meeting of Board of Directors, both scheduled for June 27, 2018.
1.Reason for Change
Kissei reviews management structure to challenge to responding some issues arising from change of the business environment.
2.New Roles
New Title
Name
Current Title
President and COO
Yoshio Furihata
Managing Director,
Member of the board,
Head of Clinical Development Division
Member of the board,
Director, Adviser
Masaki Morozumi
President and COO
3.Resume of the new President
Name
Resume
Shares held
Yoshio Furihata
(DOB:
January 12, 1962)
April 1984 Joined the Company
October 2000 Representative of Kissei Pharma Europe, Ltd.
April 2007 Director of Business Development
June 2008 Member of the board,
Director of Business Development
June 2010 Member of the board,
Director of Corporate Strategy and Planning Department
June 2012 Member of the board,
Head of Clinical Development Division
June 2016 Managing Director,
Member of the board,
Head of Clinical Development Division
(to the present)
8,200shares
4.Effective date: June 27, 2018
Attachments
Original document
Permalink
Disclaimer
Kissei Pharmaceutical Co. Ltd. published this content on 23 April 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 23 April 2018 06:11:19 UTC
KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.